M&A

Bayer considering sale of Animal Health business (€6-7bn)
Bayer considering sale of Animal Health business (€6-7bn)
GoinPharma
Bayer
animal health
M&A
Flag link:
What’s behind the pharmaceutical sector’s M&A push
What’s behind the pharmaceutical sector’s M&A push
McKinsey
M&A
innovation
tax reform
Flag link:
Walgreens Hints More Partnerships, Not Big Deals In The Future
Walgreens Hints More Partnerships, Not Big Deals In The Future
Forbes
Walgreens
M&A
Flag link:
With Vernalis Buy, Ligand Adds to Portfolio, Establishes U.K. Presence
With Vernalis Buy, Ligand Adds to Portfolio, Establishes U.K. Presence
Xconomy
Ligand Pharmaceuticals
Vernalis
M&A
Flag link:
Disgruntled Takeda alums demand a window into $62B Shire buy
Disgruntled Takeda alums demand a window into $62B Shire buy
Fierce Pharma
Takeda
Shire
M&A
Flag link:
Few biopharma buyouts in quiet third quarter
Few biopharma buyouts in quiet third quarter
EP Vantage
M&A
Flag link:
Will new Pfizer CEO Bourla get back on the megadeal train?
Will new Pfizer CEO Bourla get back on the megadeal train?
Fierce Pharma
Pfizer
M&A
Pharma CEOs
Albert Bourla
Flag link:
Is Stryker on a Buying Spree That Could Rival Boston Scientific’s?
Is Stryker on a Buying Spree That Could Rival Boston Scientific’s?
Medical Devices and Diagnostics Industry
devices
M&A
Stryker
Boston Scientific
Invuity
HyperBranch
K2M
Flag link:
Judge frees Fresenius from buyout, citing 'extensive and recurring' data problems at Akorn
Judge frees Fresenius from buyout, citing 'extensive and recurring' data problems at Akorn
Fierce Pharma
Akorn
Fresenius
M&A
Flag link:
Roche pays €70M upfront for Tusk’s preclinical Treg depleter
Roche pays €70M upfront for Tusk’s preclinical Treg depleter
Fierce Biotech
Roche
Tusk Therapeutics
M&A
Flag link:
Hologic Finds Focal Point in Breast Health with New Acquisition
Hologic Finds Focal Point in Breast Health with New Acquisition
Medical Devices and Diagnostics Industry
Hologic
devices
M&A
Focal Therapeutics
Flag link:
Alexion to buy biotech firm Syntimmune for up to $1.2 billion
Alexion to buy biotech firm Syntimmune for up to $1.2 billion
Reuters
Alexion
Syntimmune
M&A
Flag link:
Tax Reform No Shot In Arm For Pharma Deals
Tax Reform No Shot In Arm For Pharma Deals
Forbes
M&A
tax reform
taxes
Flag link:
Could troubled Mylan swing a sale to private equity buyer? One analyst thinks so
Could troubled Mylan swing a sale to private equity buyer? One analyst thinks so
Fierce Pharma
Mylan Labs
M&A
Flag link:
Medtronic is all-in on surgical robotics with $1.6B Mazor buy
Medtronic is all-in on surgical robotics with $1.6B Mazor buy
Mass Device
Medtronic
devices
M&A
Mazor Robotics
Flag link:
More Changes to the Pharmacy Industry Coming as DOJ Approves Cigna-Express Scripts Deal
More Changes to the Pharmacy Industry Coming as DOJ Approves Cigna-Express Scripts Deal
BioSpace
Cigna
Express Scripts
DOJ
M&A
Flag link:
BREAKING: Cigna-Express Scripts merger cleared by DOJ
BREAKING: Cigna-Express Scripts merger cleared by DOJ
Healthcare Dive
Cigna
Express Scripts
M&A
PBMs
DOJ
Flag link:
Supernus adds epilepsy candidate with $185M Biscayne buy
Supernus adds epilepsy candidate with $185M Biscayne buy
Fierce Biotech
Supernus
M&A
Biscayne Neurotherapeutics
epilepsy
Flag link:
Allergan fills out medical aesthetics pipeline with $195M Bonti deal
Allergan fills out medical aesthetics pipeline with $195M Bonti deal
Biopharma Dive
Allergan
Bonti
M&A
medical aesthetics
Flag link:
Galapagos opposes takeover attempt by Gilead
Galapagos opposes takeover attempt by Gilead
GoinPharma
Galapagos
Gilead Sciences
M&A
Flag link:

Pages